CMA imposes substantial fines on pharma firms for overcharging the NHS
Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets
Read More
Tag: hydrocortisone
Diurnal files Chronocort in the EU
If approved, the firm will be able to offer lifelong treatment for the rare condition congenital adrenal hyperplasia
Read More
Four new therapies to be funded by NHS Scotland
The Scottish Medicines Consortium has endorsed NHS funding for four therapies, offering new treatment options for acute myeloid leukaemia, Still’s disease, adrenal insufficiency and psoriatic arthritis.
Read More
Pharma firms accused of forming drug cartel
Concordia and Actavis UK stand accused of breaking UK competition law by artificially lifting the cost of hydrocortisone tablets to the National Health Service with a deal that delayed competition to the drug.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
